Insider Trading History of Aker Christopher Ray


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Aker Christopher Ray since year 2005. The trader's CIK number is 1762611. At the time of the last reporting, Aker Christopher Ray was the Sr. VP & General Counsel of Regulus Therapeutics Inc. . (stock ticker symbol RGLS). See this page for all insider trading activities at Regulus Therapeutics Inc. .


Stock purchases, sales, and option exercises reported by insider Aker Christopher Ray since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-10-01 RGLS Regulus Therapeutics Inc. Sale 2,346 .68 1,602
2019-08-15 RGLS Regulus Therapeutics Inc. Sale 899 .55 495
2019-07-01 RGLS Regulus Therapeutics Inc. Sale 2,225 1.31 2,919
2019-05-15 RGLS Regulus Therapeutics Inc. Sale 6,950 1.41 9,799
2019-04-01 RGLS Regulus Therapeutics Inc. Sale 2,710 .98 2,658

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aker Christopher Ray (Sr. VP & General Counsel of Regulus Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month